Onyvax develops cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells.
Business Model:
Revenue: $10M
Employees: 2-10
Address:
City: Bradford
State: Somerset
Zip:
Country: United Kingdom
Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax&s;s products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2000 | Venture Round | 5 | $14.9M |
3i Group Alice Ventures Alta Berkeley Venture Partners Excalibur Fund Managers SR One 3i Group Alice Ventures Alta Berkeley Venture Partners Excalibur Fund Managers SR One |
12/1997 | Venture Round | 3 | - |
3i Group Alta Berkeley Venture Partners SR One 3i Group Alta Berkeley Venture Partners SR One |
5/2006 | Series C | 5 | $14.9M |
3i Group Alice Ventures Alta Berkeley Venture Partners Excalibur Fund Managers SR One 3i Group Alice Ventures Alta Berkeley Venture Partners Excalibur Fund Managers SR One |
12/1997 | Venture Round | 3 | - |
3i Group Alta Berkeley Venture Partners SR One 3i Group Alta Berkeley Venture Partners SR One |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|